CAS NO: | 9008-22-4 |
包装 | 价格(元) |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | Laminaran is anβ-1-3-glucanand a typical ligand forDectin-1fromEisenia Bicyclis, has potent immunomodulating, radioprotective, and anticancer activities[1]. Laminaran is made up of β (1→3)-glucan with β (1→6)-branches and can be catalyzed by enzymes such as laminarinase (EC 3.2.1.6) that breaks the β (1→3) bonds[2]. Laminaran is a promisingimmune stimulatory moleculefor use incancer immunotherapy[3]. | ||||||||||||||||||||||||
体外研究 (In Vitro) | Laminaran (100-800 μg/mL; 24 hours) is not cytotoxic against normal epidermal cells JB6 Cl41 and human melanoma cells SK-MEL-28, the percentage of inhibition of living cells number is less than 15 % at concentrations range up to 800 μg/mL after 24 h of treatment[1].Laminaran (200 μg/mL; 24-72 hours)does not cause any growth inhibition of SK-MEL-28 cells after 24 and 48 h of treatment, but decreases cells proliferation by 36 % after 72 h of treatment[1].Laminaran (25-50 μg/mL; 24 hours) at low concentration does not influence the phosphorylation of c-Raf (Ser259), ERK1/2 (Tyr202/Tyr204), and MEK1/2 (Ser 221) kinases as well as total expression level of investigated proteins. But decreases p-MEK, p-ERK1/2 at 50 μg/mL[1]. Cell Viability Assay[1]
Cell Proliferation Assay[1]
Western Blot Analysis[1]
| ||||||||||||||||||||||||
体内研究 (In Vivo) | Laminaran (intravenous injection; 12.5, 25, and 50 mg/kg; 21 days) and OVA (50 μg) combination significanly decreases the tumor masses when it compares with the PBS-, OVA-, and laminarin-treated mice[3].
| ||||||||||||||||||||||||
性状 | Solid | ||||||||||||||||||||||||
Formula | C18H32O16 | ||||||||||||||||||||||||
CAS 号 | 9008-22-4 | ||||||||||||||||||||||||
中文名称 | 昆布多糖;褐藻淀粉 | ||||||||||||||||||||||||
结构分类 |
| ||||||||||||||||||||||||
来源 |
Eisenia Bicyclis | ||||||||||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||||||||||
储存方式 |
| ||||||||||||||||||||||||
溶解性数据 | In Vitro: DMSO : 100 mg/mL(Need ultrasonic) H2O : 16.67 mg/mL(Need ultrasonic) In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
*以上所有助溶剂都可在本网站选购。 |